SARS-CoV-2 Spike RBD Neutralizing Antibody, monoclonal, Chimeric

Human IgM/kappa

For long term storage, the product should be stored at lyophilized state at -20°C or lower.Please protect from light and avoid repeated freeze-thaw cycles.This product is stable after storage at:-20°C to -70°C for 12 months in lyophilized state; -70°C for 3 months under sterile conditions after reconstitution.

It's been reported that Coronavirus can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

Batch dependent

Anti-SARS-CoV-2 Spike RBD Neutralizing antibody, Human IgM is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from human 293 cells (HEK293).

Surface glycoprotein

Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.